Applying siRNA targeting TKTL1 in nasopharyngeal carcinoma cell lines CNE2 and HONE1, Dong and Wang reported a drop in cell viability and in levels of NADPH and ribose 5-phosphate [22]. This evidence concerns the gene TKTL1 and nasopharyngeal carcinoma.